CRYSTAL, THANKS. WELL, WE HAVE MORE BREAKING NEWS OUT OF CLINTON TONIGHT. LONGTIME MAYOR PHIL FISHER IS SET TO RETIRE. >> YEAH, THIS SURPRISE ANNOUNCEMENT COMING WITH ALMOST A FULL YEAR LEFT ON HIS ...

Exact Sciences, which has for years sold a stool-based colon cancer test, on Monday announced that a blood-based test it’s developing showed promise in accurately detecting the disease.

Exact Sciences released data from a study of its blood-based colorectal cancer screening test that showed sensitivities of 88.3% for colorectal cancer and 31.2% for advanced precancerous lesions.

As it works to diversify its methods for catching early cases of colorectal cancer, Exact Sciences has put forward clinical data showing its blood-based test can help spot growing tumors as well ...

Peterson believes that the test, which has been over a decade in the making, has a strong potential for inclusion in USPSTF guidelines, especially given its competitive cost structure and Exact ...

test showed promising sensitivity and specificity rates from a substantial patient study, outperforming Massaro’s expectations. These results hint at the potential for Exact Sciences to secure ...

Over the weekend, during the lead-up to Exact Sciences announcing data from a blood-based colon cancer test, Guardant Health co-CEO AmirAli Talasaz challenged Exact’s CEO, Kevin Conroy ...